Andreas Hettich GmbH
Overview
Established in 1904 and headquartered in Tuttlingen, Germany, Andreas Hettich GmbH is a renowned global leader in the design and production of laboratory equipment, with a primary focus on centrifuges and incubators. As a family-owned enterprise, it embodies the principles of German engineering, characterized by precision, quality, and sustainability. The company employs approximately 500 staff members at its 18,000 m² facility, catering to a wide array of laboratory needs worldwide through high-quality manufacturing processes.
Product Offering
- Centrifuges: With a portfolio of over 20 models ranging from manual options to robust floor-standing units for high-volume samples, Andreas Hettich GmbH addresses diverse laboratory requirements while ensuring energy-efficient performance.
- Incubators: The Hettich HettCube series stands out for its user-friendly features and various sizes, serving applications in microbiology and biotechnology.
All products are IVDR or Medical Device certified and TÜV tested, signifying adherence to the highest safety standards.
Corporate Philosophy
Committed to sustainability and social responsibility, Hettich integrates environmental consciousness into its operations by favoring climate-friendly logistics and local suppliers. This dedication is certified by DIN EN ISO 14001. The company's social responsibility initiatives extend to supporting educational programs and enhancing employee benefits.
Management Team
- Kristina Apolinaris Eberle, CEO, also holds the position of President Director at PT.Prima Alkesindo Nusantara - Indonesia.
- Klaus-Günter Eberle, co-CEO, is known for his global innovation expertise and advocacy for a "quality economy."
- Christoph Pabst, CFO, and Country Manager for India, reinforces support for healthcare professionals.
- Leopold Frank, CTO, ensures product excellence by using tested materials.
Global Presence
Through subsidiaries in Europe, the USA, and Singapore, alongside authorized distributors worldwide, Hettich guarantees broad access to its products and support network. In 2023, the company reported a turnover of 1.3 billion euros, underscoring its strong market presence and growth trajectory.
Key Developments and Strategic Initiatives
- Acquired Philipp Kirsch GmbH, enhancing its foothold in the life science equipment sector.
- Entered a growth partnership with Bregal Unternehmerkapital to drive strategic development and innovation.
- Introduced the ROTANTA 460 centrifuge, notable for its high throughput and versatile accessory options.
Commitment to Quality
Employing a rigorous focus on precision, all product components are manufactured in-house. The process spans metal and plastic casting, injection molding, and lasering, ensuring superior quality from design to assembly.
Contact Information
Address: Andreas Hettich GmbH, Föhrenstraße 12, D-78532 Tuttlingen, Germany
Phone: +49 7461 705-0
Email: info@hettichlab.com
Website: [hettichlab.com](https://www.hettichlab.com/)
Competitive Analysis
Key Competitors
- Thermo Fisher Scientific Inc.: A global leader in serving science, based in the USA, with over $40 billion in revenue, offering a comprehensive range of laboratory products and diagnostic tools.
- Eppendorf SE: Headquartered in Hamburg, Germany, Eppendorf is acclaimed for its laboratory instruments, focusing on liquid and sample handling. The company employs over 5,100 people globally.
- Danaher Corporation (Beckman Coulter, Inc.): A key player in laboratory diagnostics, Beckman Coulter, based in California, USA, provides solutions in clinical diagnostics and life sciences.
- HERMLE Labortechnik GmbH: Specializes in laboratory centrifuges, operational since 1956 in Wehingen, Germany.
- Qiagen NV: Offers molecular testing solutions, headquartered in Germany, focusing on diagnostics and biotech.
Strategic Position and Opportunities
Andreas Hettich GmbH upholds a strong position in the laboratory equipment market by prioritizing high-quality centrifuge production. Competing against major global entities, it leverages its reputation and specialized knowledge to secure a dedicated market segment. Innovations and adaptation to technological advancements are critical for maintaining its competitive edge. There is potential for growth by expanding the product portfolio, investing in R&D, and strengthening customer service and global distribution. Strategic partnerships, especially with research and biotech firms, could facilitate access to emerging markets and applications.
This comprehensive report outlines Andreas Hettich GmbH's corporate and competitive landscape, highlighting its strategic positioning and opportunities for advancement in the industry.
